Last reviewed · How we verify
Gout — Treatment Landscape & Competitive Intelligence
Rheumatology
9 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Aleve | naproxen | Generic (originally Syntex) | NSAID | Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Prostaglandin G/H synthase 1 | 1976-01-01 | |
| Aloprim | ALLOPURINOL | Casper Pharma Llc | Xanthine Oxidase Inhibitor [EPC] | Xanthine dehydrogenase/oxidase | 1966-01-01 | |
| Colcrys | COLCHICINE | Scilex Pharms | Alkaloid [EPC] | Serine/threonine-protein kinase pim-1 | 1961-01-01 | |
| Indom | Indom | University of Trieste | Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase | |||
| Uriadec | TOPIROXOSTAT | Senwa Kegaku Kenkyushp | ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase | |||
| KRYSTEXXA® | KRYSTEXXA® | Selecta Biosciences, Inc. | ||||
| Benzbromaron | Benzbromaron | Amsterdam UMC, location VUmc | Eyes absent homolog 2, Eyes absent homolog 3, ATP-binding cassette sub-family G member 2 | |||
| indometacin | indometacin | Maastricht University Medical Center | Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase | |||
| Urece | DOTINURAD | Fuji Yakuhin | Solute carrier family 22 member 12 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
- — Aloprim · FDA · approved · US
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 4 drugs in Gout
- Amsterdam UMC, location VUmc · 1 drug in Gout
- Casper Pharma Llc · 1 drug in Gout
- Fuji Yakuhin · 1 drug in Gout
- Generic (originally Syntex) · 1 drug in Gout
- Maastricht University Medical Center · 1 drug in Gout
- Scilex Pharms · 1 drug in Gout
- Selecta Biosciences, Inc. · 1 drug in Gout
- Senwa Kegaku Kenkyushp · 1 drug in Gout
- University of Trieste · 1 drug in Gout
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Gout:
Cite this brief
Drug Landscape (2026). Gout — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/gout. Accessed 2026-05-15.
Related
- Gout full disease profile — treatment pathway, diagnostics, guidelines
- Rheumatology area landing
- Browse all CI briefs
- Build a custom feed